A Pennsylvania jury awarded $3 million to the family of a 5-year-old born with cleft palate and lip as a result of the mother taking Topomax during pregnancy. The jury ruled that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to warn of the risk of birth defects associated with the drug. “On behalf of the Anderson family and their child,” said a lawyer for the family, “we are proud to have held Janssen Pharmaceuticals responsible for its decision to sell Topamax without adequately warning families of the serious risks present during pregnancy.”
